These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 28666800

  • 41. The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS.
    Keerie A, Brown-Wright H, Kirkland I, Grierson A, Alix JJP, Holscher C, Mead RJ.
    Sci Rep; 2021 Aug 23; 11(1):17027. PubMed ID: 34426623
    [Abstract] [Full Text] [Related]

  • 42. Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson's Disease.
    Panagaki T, Randi EB, Szabo C, Hölscher C.
    J Parkinsons Dis; 2023 Aug 23; 13(7):1149-1174. PubMed ID: 37718851
    [Abstract] [Full Text] [Related]

  • 43. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP.
    Neurochem Int; 2014 Jan 23; 65():1-13. PubMed ID: 24333323
    [Abstract] [Full Text] [Related]

  • 44. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T.
    Neuropharmacology; 2011 Dec 23; 61(8):1441-51. PubMed ID: 21903118
    [Abstract] [Full Text] [Related]

  • 45. Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases.
    Hölscher C.
    Sheng Li Xue Bao; 2014 Oct 25; 66(5):497-510. PubMed ID: 25331995
    [Abstract] [Full Text] [Related]

  • 46. GIP has neuroprotective effects in Alzheimer and Parkinson's disease models.
    Zhang ZQ, Hölscher C.
    Peptides; 2020 Mar 25; 125():170184. PubMed ID: 31705913
    [Abstract] [Full Text] [Related]

  • 47. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease.
    Glotfelty EJ, Olson L, Karlsson TE, Li Y, Greig NH.
    Expert Opin Investig Drugs; 2020 Jun 25; 29(6):595-602. PubMed ID: 32412796
    [Abstract] [Full Text] [Related]

  • 48. Reduced incretin receptor trafficking upon activation enhances glycemic control and reverses obesity in diet-induced obese mice.
    Bauri R, Bele S, Edelli J, Reddy NC, Kurukuti S, Devasia T, Ibrahim A, Rai V, Mitra P.
    Am J Physiol Cell Physiol; 2024 Jul 01; 327(1):C74-C96. PubMed ID: 38738303
    [Abstract] [Full Text] [Related]

  • 49. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
    Finan B, Ma T, Ottaway N, Müller TD, Habegger KM, Heppner KM, Kirchner H, Holland J, Hembree J, Raver C, Lockie SH, Smiley DL, Gelfanov V, Yang B, Hofmann S, Bruemmer D, Drucker DJ, Pfluger PT, Perez-Tilve D, Gidda J, Vignati L, Zhang L, Hauptman JB, Lau M, Brecheisen M, Uhles S, Riboulet W, Hainaut E, Sebokova E, Conde-Knape K, Konkar A, DiMarchi RD, Tschöp MH.
    Sci Transl Med; 2013 Oct 30; 5(209):209ra151. PubMed ID: 24174327
    [Abstract] [Full Text] [Related]

  • 50. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
    Sun X, Xiong Z, Zhang Y, Meng Y, Xu G, Xia Z, Li J, Zhang R, Ke Z, Xia Z, Hu Y.
    J Neurochem; 2012 Mar 30; 120(6):1072-83. PubMed ID: 22192054
    [Abstract] [Full Text] [Related]

  • 51. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Mitra S, Ghosh N, Sinha P, Chakrabarti N, Bhattacharyya A.
    Neurosci Lett; 2016 Mar 11; 616():86-92. PubMed ID: 26827723
    [Abstract] [Full Text] [Related]

  • 52. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y, Zhang Z, Hou L, Zhang L, Zhang J, Wang Y, Liu C, Xu P, Liu L, Gai X, Lu T.
    Neurosci Lett; 2015 Jun 15; 597():132-6. PubMed ID: 25929185
    [Abstract] [Full Text] [Related]

  • 53. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct 15; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease.
    Janakiraman U, Manivasagam T, Justin Thenmozhi A, Dhanalakshmi C, Essa MM, Song BJ, Guillemin GJ.
    Physiol Behav; 2017 May 01; 173():132-143. PubMed ID: 28185878
    [Abstract] [Full Text] [Related]

  • 56. Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders.
    Hölscher C.
    Br J Pharmacol; 2022 Feb 01; 179(4):695-714. PubMed ID: 33900631
    [Abstract] [Full Text] [Related]

  • 57. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
    Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH.
    Proc Natl Acad Sci U S A; 2009 Jan 27; 106(4):1285-90. PubMed ID: 19164583
    [Abstract] [Full Text] [Related]

  • 58. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
    Al-Zamel N, Al-Sabah S, Luqmani Y, Adi L, Chacko S, Schneider TD, Krasel C.
    Int J Mol Sci; 2019 Jul 19; 20(14):. PubMed ID: 31330984
    [Abstract] [Full Text] [Related]

  • 59. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
    Jalewa J, Sharma MK, Hölscher C.
    J Neurochem; 2016 Oct 19; 139(1):55-67. PubMed ID: 27412483
    [Abstract] [Full Text] [Related]

  • 60. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L, Xue L, Zheng J, Tian X, Zhang Y, Tong Q.
    Behav Brain Res; 2019 Jan 01; 356():483-489. PubMed ID: 29885849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.